Search Results
Search for "Cyclophosphamide" returned 9 results
Showing 1-9 out of 9
| DrugBank ID | Name | Formula | Weight |
|---|---|---|---|
DB00531
|
Cyclophosphamide | C7H15Cl2N2O2P | 261.0860 |
| ... Pws Iv (Cyclophosphamide + Sodium Chloride) Cyclophosphamide Cyclophosphamide is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating ... | |||
| DB01181
|
Ifosfamide | C7H15Cl2N2O2P | 261.0860 |
| ... C7H15Cl2N2O2P Approved Small Molecule Positional isomer of cyclophosphamide which is active as an alkylating agent and an immunosuppressive agent. [PubChem] Powder, for solution Intravenous ... | |||
| DB00993
|
Azathioprine | C9H7N7O2S | 277.2630 |
| ... Molecule An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on ... | |||
| DB04572
|
Thiotepa | C6H12N3PS | 189.2183 |
| ... monitor for changes in the therapeutic and adverse effects of Cyclophosphamide if Thiotepa is initiated, discontinued or dose changed. Irinotecan Thiotepa, a strong CYP2B6 inhibitor, may ... | |||
| DB00958
|
Carboplatin | C6H12N2O4Pt | 371.2540 |
| One established combination regimen consists of PARAPLATIN and cyclophosphamide. azanide; cyclobutane-1,1-dicarboxylic acid; platinum D01363 Alkylating agents work by three different mechanisms: 1 ... | |||
| DB01008
|
Busulfan | C6H14O6S2 | 246.3020 |
| ... 2.5 hours COVZYZSDYWQREU-UHFFFAOYAO For use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic ... | |||
| DB00196
|
Fluconazole | C13H12F2N6O | 306.2708 |
| ... Clorazepate Increases the effect of the benzodiazepine Cyclophosphamide Reduces metabolism and clearance of cyclophosphamide Cyclosporine Increases the effect of the immunosuppressant Diazepam ... | |||
| DB00390
|
Digoxin | C41H64O14 | 780.9385 |
| ... patients Colestipol The resin decreases the effect of digoxin Cyclophosphamide The antineoplasic agent decreases the effect of digoxin Cyclosporine Cyclosporine increases the effect of digoxin ... | |||
| DB00072
|
Trastuzumab | C6470H10012N1726O2013S42 | 145531.5000 |
| Monitor closely for signs and symptoms of adverse events. Cyclophosphamide Trastuzumab may increase the risk of neutropenia and anemia. Monitor closely for signs and symptoms of adverse events. | |||
Showing 1-9 out of 9